Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Bongin Yoo
Impact of Omalizumab Treatment Withdrawal After 24 and 48 Weeks in Patients With Chronic Idiopathic Urticaria: Results From the XTEND-CIU Study
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Related publications
Omalizumab Response in Patients With Chronic Idiopathic Urticaria: Insights From the XTEND-CIU Study
Journal of the American Academy of Dermatology
Dermatology
Impact of Omalizumab on Patient Reported Outcomes in Chronic Idiopathic Urticaria: Results From XTEND-CIU, a 48-Week, Randomized, Placebo-Controlled Study
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Omalizumab Treatment Patterns in Chronic Idiopathic Urticaria (CIU): Evidence From a Large Allergy Practice in the United States (US)
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Omalizumab Treatment in Patients With Chronic Spontaneous Urticaria
Bőrgyógyászati és Venerológiai Szemle
Long-Term Outcomes of Omalizumab in Chronic Idiopathic Urticaria (CIU): Evidence From a Large Allergy Practice in the United States (US)
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Re-Evaluation of Need and Tapering of Omalizumab in Chronic Idiopathic Urticaria
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Omalizumab for Chronic Idiopathic Urticaria: Potential to Taper Dose and Frequency?
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Omalizumab vs. Placebo in the Management of Chronic Idiopathic Urticaria: A Systematic Review
World Allergy Organization Journal
Immunology
Pulmonary
Allergy
Respiratory Medicine
Efficacy of Omalizumab in Treatment-Resistant Chronic Spontaneous Urticaria
Asim, Allerji, Immunoloji
Respiratory Medicine
Pulmonary
Allergy
Immunology
